miR-216a may inhibit pancreatic tumor growth by targeting JAK2.

FEBS Lett

Department of General Surgery, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, PR China. Electronic address:

Published: August 2015

This study was aimed to investigate miR-216a expression in pancreatic cancer and determine its effects on proliferation. miR-216a was found downregulated in pancreatic cancer tissues as compared to benign pancreatic lesions. JAK2 was identified as a miR-216a gene target. Further, in vivo treatment of PANC-1 tumors with miR-216a reduced JAK2 protein levels in the tumor and reduced tumor volume. In conclusion, miR-216a may function as a tumor suppressor regulating pancreatic cancer cells by targeting the JAK/STAT pathway. Further studies with a larger number of patient samples are necessary to fully explore the diagnostic and therapeutic potential of miR-216a for pancreatic cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2015.06.036DOI Listing

Publication Analysis

Top Keywords

pancreatic cancer
16
mir-216a
7
pancreatic
6
mir-216a inhibit
4
inhibit pancreatic
4
tumor
4
pancreatic tumor
4
tumor growth
4
growth targeting
4
targeting jak2
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!